Followers | 875 |
Posts | 36066 |
Boards Moderated | 8 |
Alias Born | 03/22/2016 |

Friday, November 01, 2024 10:14:19 AM
Recent AVTE News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2025 08:05:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/25/2025 08:30:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2025 08:37:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2025 12:07:00 PM
- Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals • PR Newswire (US) • 04/21/2025 12:00:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/09/2025 08:20:40 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/09/2025 08:11:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2025 08:09:42 PM
- Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences • PR Newswire (US) • 04/09/2025 08:05:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/09/2025 11:01:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2025 11:00:47 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/07/2025 12:46:51 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/07/2025 12:42:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2025 12:39:58 PM
- Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences • PR Newswire (US) • 04/07/2025 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2025 11:30:28 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/26/2025 08:54:34 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/26/2025 04:15:34 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/03/2025 09:45:17 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/24/2025 02:57:59 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/10/2025 09:23:49 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/04/2025 10:16:57 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/24/2025 09:17:38 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/22/2025 01:45:54 PM
FEATURED Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM
Patented, Groundbreaking Blockchain for Public Companies 'BlackStar Digital Trading PlatformTM' can Facilitate U.S. Registered Securities to Trade on Blockchain Without Tokens. • BEGI • Jul 1, 2025 12:54 PM
UC Asset (UCASU) Public Offering's Acquisition Target Reported Better Results • UCASU • Jul 1, 2025 9:15 AM